{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T04:14:51Z","timestamp":1794975291507,"version":"4.9.1"},"reference-count":176,"publisher":"European Respiratory Society (ERS)","issue":"175","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir Rev"],"accepted":{"date-parts":[[2024,10,24]]},"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:p>Asthma is considered severe if it remains uncontrolled despite optimal conventional therapy, characterised by poor symptom control, frequent exacerbations and increased exposure to systemic corticosteroids. This has a significant impact on morbidity, mortality and healthcare resource utilisation. Recent advances in the understanding of asthma heterogeneity and immunopathogenesis have helped delineate precise disease pathways. The discovery of these pivotal pathways has led to the development of highly effective biologic therapies. Currently available asthma biologics target immunoglobulin E, interleukin (IL)-5\/IL-5R\u03b1, IL-4R\u03b1 and thymic stromal lymphopoietin. Identification of specific asthma phenotypes, utilising easily measurable biomarkers, has paved the way towards personalised and precision asthma management. Biologic therapies play a significant role in reducing exacerbations, hospitalisations and the need for maintenance systemic steroids, while also improving the quality of life in patients with severe asthma. The evidence for their clinical efficacy comes from randomised controlled trials (RCTs), extension studies, metanalyses and real-world data. This review synthesises findings from early, pivotal RCTs and subsequent studies following the approval of biologics for severe asthma. The safety and efficacy data from these studies, completed in a variety of settings, provide practical perspectives on their application and enhance their generalisability.<\/jats:p>","DOI":"10.1183\/16000617.0088-2024","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T04:20:40Z","timestamp":1736310040000},"page":"240088","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":125,"title":["Biologics in severe asthma: a state-of-the-art review"],"prefix":"10.1183","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9098-6982","authenticated-orcid":false,"given":"Bishal","family":"Gyawali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve N.","family":"Georas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3167-1152","authenticated-orcid":false,"given":"Sandhya","family":"Khurana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2025,1,8]]},"reference":[{"key":"2025032603000536000_34.175.240088.1","doi-asserted-by":"publisher","DOI":"10.1111\/all.15473"},{"key":"2025032603000536000_34.175.240088.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2032506"},{"key":"2025032603000536000_34.175.240088.3","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201810-1944CI"},{"key":"2025032603000536000_34.175.240088.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2019.08.462"},{"key":"2025032603000536000_34.175.240088.5","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00202013"},{"key":"2025032603000536000_34.175.240088.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.08.042"},{"key":"2025032603000536000_34.175.240088.7","first-page":"825","article-title":"Incremental cost burden among patients with severe uncontrolled asthma in the United States","volume":"29","author":"Burnette","year":"2023","journal-title":"J Manag Care Spec Pharm"},{"key":"2025032603000536000_34.175.240088.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2020.105919"},{"key":"2025032603000536000_34.175.240088.9","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0193-2022"},{"key":"2025032603000536000_34.175.240088.10","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00248-2022"},{"key":"2025032603000536000_34.175.240088.11","unstructured":"Genentech . Highlights of prescribing information. Date last accessed: April 2024. Date last updated: July 2016. www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/103976s5225lbl.pdf"},{"key":"2025032603000536000_34.175.240088.12","unstructured":"European Medicines Agency . Committee for medicinal products for human use post-authorisation summary of positive opinion for Xolair. Date last accessed: April 2024. Date last updated: 25 June 2009. www.ema.europa.eu\/en\/documents\/smop\/chmp-post-authorisation-summary-positive-opinion-xolair-25-june-2009_en.pdf"},{"key":"2025032603000536000_34.175.240088.13","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.117880"},{"key":"2025032603000536000_34.175.240088.14","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.01.00092101"},{"key":"2025032603000536000_34.175.240088.15","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.02.00278102"},{"key":"2025032603000536000_34.175.240088.16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2004.00550.x"},{"key":"2025032603000536000_34.175.240088.17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2004.00533.x"},{"key":"2025032603000536000_34.175.240088.18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2004.00772.x"},{"key":"2025032603000536000_34.175.240088.19","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-154-9-201105030-00002"},{"key":"2025032603000536000_34.175.240088.20","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00010403"},{"key":"2025032603000536000_34.175.240088.21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2010.02522.x"},{"key":"2025032603000536000_34.175.240088.22","doi-asserted-by":"publisher","DOI":"10.3109\/02770903.2011.648296"},{"key":"2025032603000536000_34.175.240088.23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2004.00770.x"},{"key":"2025032603000536000_34.175.240088.24","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003559"},{"key":"2025032603000536000_34.175.240088.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2009.06.014"},{"key":"2025032603000536000_34.175.240088.26","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-1372"},{"key":"2025032603000536000_34.175.240088.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2013.04.017"},{"key":"2025032603000536000_34.175.240088.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2018.06.021"},{"key":"2025032603000536000_34.175.240088.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2022.100695"},{"key":"2025032603000536000_34.175.240088.30","doi-asserted-by":"publisher","DOI":"10.1111\/all.12815"},{"key":"2025032603000536000_34.175.240088.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2017.02.002"},{"key":"2025032603000536000_34.175.240088.32","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2019.1574571"},{"key":"2025032603000536000_34.175.240088.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2021.01.011"},{"key":"2025032603000536000_34.175.240088.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.08.054"},{"key":"2025032603000536000_34.175.240088.35","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.03130-2021"},{"key":"2025032603000536000_34.175.240088.36","unstructured":"Global Initiative for Asthma . 2023 GINA report, global strategy for asthma management and prevention. Date last accessed: 21 April 2024. Date last updated 10 July 2023. https:\/\/ginasthma.org\/2023-gina-main-report\/"},{"key":"2025032603000536000_34.175.240088.37","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-023-01106-w"},{"key":"2025032603000536000_34.175.240088.38","doi-asserted-by":"publisher","DOI":"10.1111\/all.13302"},{"key":"2025032603000536000_34.175.240088.39","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201208-1414OC"},{"key":"2025032603000536000_34.175.240088.40","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2017.1321945"},{"key":"2025032603000536000_34.175.240088.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2018.04.043"},{"key":"2025032603000536000_34.175.240088.42","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202310-1730OC"},{"key":"2025032603000536000_34.175.240088.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2007.01.011"},{"key":"2025032603000536000_34.175.240088.44","doi-asserted-by":"publisher","DOI":"10.1186\/s13223-019-0337-2"},{"key":"2025032603000536000_34.175.240088.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2010.06.001"},{"key":"2025032603000536000_34.175.240088.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.02.007"},{"key":"2025032603000536000_34.175.240088.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.07.038"},{"key":"2025032603000536000_34.175.240088.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2022.11.008"},{"key":"2025032603000536000_34.175.240088.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.08.025"},{"key":"2025032603000536000_34.175.240088.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2020.02.002"},{"key":"2025032603000536000_34.175.240088.51","unstructured":"GlaxoSmithKline . Highlights of prescribing information. Date last accessed: April 2024. Date last updated: March 2023. www.gsksource.com\/pharma\/content\/dam\/GlaxoSmithKline\/US\/en\/Prescribing_Information\/Nucala\/pdf\/NUCALA-PI-PIL-IFU-COMBINED.PDF"},{"key":"2025032603000536000_34.175.240088.52","unstructured":"European Medicines Agency . Summary of product characteristics. Date last accessed: April 2024. Date last updated: 16 July 2024. www.ema.europa.eu\/en\/documents\/product-information\/nucala-epar-product-information_en.pdf"},{"key":"2025032603000536000_34.175.240088.53","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03496-6"},{"key":"2025032603000536000_34.175.240088.54","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200701-085OC"},{"key":"2025032603000536000_34.175.240088.55","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60988-X"},{"key":"2025032603000536000_34.175.240088.56","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1403290"},{"key":"2025032603000536000_34.175.240088.57","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1403291"},{"key":"2025032603000536000_34.175.240088.58","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(17)30125-X"},{"key":"2025032603000536000_34.175.240088.59","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2016.07.010"},{"key":"2025032603000536000_34.175.240088.60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.09.033"},{"key":"2025032603000536000_34.175.240088.61","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2019.07.007"},{"key":"2025032603000536000_34.175.240088.62","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00151-2020"},{"key":"2025032603000536000_34.175.240088.63","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S236609"},{"key":"2025032603000536000_34.175.240088.64","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.03.042"},{"key":"2025032603000536000_34.175.240088.65","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00745-2022"},{"key":"2025032603000536000_34.175.240088.66","doi-asserted-by":"publisher","DOI":"10.1080\/02770903.2021.2008431"},{"key":"2025032603000536000_34.175.240088.67","doi-asserted-by":"publisher","DOI":"10.1080\/02770903.2022.2102036"},{"key":"2025032603000536000_34.175.240088.68","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2020.41.200043"},{"key":"2025032603000536000_34.175.240088.69","doi-asserted-by":"publisher","DOI":"10.1111\/cea.13601"},{"key":"2025032603000536000_34.175.240088.70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2022.05.042"},{"key":"2025032603000536000_34.175.240088.71","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00396-2021"},{"key":"2025032603000536000_34.175.240088.72","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(16)30031-5"},{"key":"2025032603000536000_34.175.240088.73","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2023.07.024"},{"key":"2025032603000536000_34.175.240088.74","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02420-2019"},{"key":"2025032603000536000_34.175.240088.75","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2022-219781"},{"key":"2025032603000536000_34.175.240088.76","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0805435"},{"key":"2025032603000536000_34.175.240088.77","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2021.05.021"},{"key":"2025032603000536000_34.175.240088.78","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-024-02885-2"},{"key":"2025032603000536000_34.175.240088.79","doi-asserted-by":"publisher","DOI":"10.1111\/cea.14112"},{"key":"2025032603000536000_34.175.240088.80","unstructured":"Teva Respiratory . Highlights of prescribing information. Date last accessed: April 2024. Date last updated: 9 January 2019. www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/761033lbl.pdf"},{"key":"2025032603000536000_34.175.240088.81","unstructured":"European Medicines Agency . Cinqaero. Date last accessed: April 2024. Date last updated: 26 May 2023. www.ema.europa.eu\/en\/medicines\/human\/EPAR\/cinqaero"},{"key":"2025032603000536000_34.175.240088.82","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(15)00042-9"},{"key":"2025032603000536000_34.175.240088.83","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.03.032"},{"key":"2025032603000536000_34.175.240088.84","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2017.08.024"},{"key":"2025032603000536000_34.175.240088.85","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2022.04.014"},{"key":"2025032603000536000_34.175.240088.86","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.11.060"},{"key":"2025032603000536000_34.175.240088.87","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2018.08.021"},{"key":"2025032603000536000_34.175.240088.88","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.03.018"},{"key":"2025032603000536000_34.175.240088.89","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2019.09.036"},{"key":"2025032603000536000_34.175.240088.90","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2019.07.038"},{"key":"2025032603000536000_34.175.240088.91","unstructured":"AstraZeneca . Highlights of prescribing information. Date last accessed: April 2024. Date last updated: 3 October 2019. www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/761070s000lbl.pdf"},{"key":"2025032603000536000_34.175.240088.92","unstructured":"European Medicines Agency . Summary of product characteristics. Date last accessed: April 2024. Date last updated: 13 February 2024. https:\/\/ec.europa.eu\/health\/documents\/communityregister\/2018\/20180108139598\/anx_139598_en.pdf"},{"key":"2025032603000536000_34.175.240088.93","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31324-1"},{"key":"2025032603000536000_34.175.240088.94","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31322-8"},{"key":"2025032603000536000_34.175.240088.95","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(18)30406-5"},{"key":"2025032603000536000_34.175.240088.96","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S227170"},{"key":"2025032603000536000_34.175.240088.97","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.02.009"},{"key":"2025032603000536000_34.175.240088.98","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2021.07.058"},{"key":"2025032603000536000_34.175.240088.99","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30414-8"},{"key":"2025032603000536000_34.175.240088.100","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.08.2083"},{"key":"2025032603000536000_34.175.240088.101","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-020-01220-9"},{"key":"2025032603000536000_34.175.240088.102","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00166-2021"},{"key":"2025032603000536000_34.175.240088.103","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S297273"},{"key":"2025032603000536000_34.175.240088.104","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01521-2023"},{"key":"2025032603000536000_34.175.240088.105","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00383-2023"},{"key":"2025032603000536000_34.175.240088.106","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(17)30344-2"},{"key":"2025032603000536000_34.175.240088.107","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00936-2018"},{"key":"2025032603000536000_34.175.240088.108","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00238-2022"},{"key":"2025032603000536000_34.175.240088.109","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1703501"},{"key":"2025032603000536000_34.175.240088.110","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00352-0"},{"key":"2025032603000536000_34.175.240088.111","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2017.1298443"},{"key":"2025032603000536000_34.175.240088.112","unstructured":"Regeneron Pharmaceuticals . Highlights of prescribing information. Date last accessed: April 2024. Date last updated: 12 April 2024. www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/761055s057lbl.pdf"},{"key":"2025032603000536000_34.175.240088.113","unstructured":"European Medicines Agency . Summary of product characteristics. Date last accessed: April 2024. Date last updated: 15 July 2024. www.ema.europa.eu\/en\/documents\/product-information\/dupixent-epar-product-information_en.pdf"},{"key":"2025032603000536000_34.175.240088.114","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1304048"},{"key":"2025032603000536000_34.175.240088.115","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30307-5"},{"key":"2025032603000536000_34.175.240088.116","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804092"},{"key":"2025032603000536000_34.175.240088.117","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804093"},{"key":"2025032603000536000_34.175.240088.118","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00322-2"},{"key":"2025032603000536000_34.175.240088.119","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2022.01.071"},{"key":"2025032603000536000_34.175.240088.120","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2023.12.043"},{"key":"2025032603000536000_34.175.240088.121","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2024.107535"},{"key":"2025032603000536000_34.175.240088.122","doi-asserted-by":"publisher","DOI":"10.1111\/all.15792"},{"key":"2025032603000536000_34.175.240088.123","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2023.11.006"},{"key":"2025032603000536000_34.175.240088.124","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2022.107058"},{"key":"2025032603000536000_34.175.240088.125","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2022.11.043"},{"key":"2025032603000536000_34.175.240088.126","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S357548"},{"key":"2025032603000536000_34.175.240088.127","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00056-2023"},{"key":"2025032603000536000_34.175.240088.128","doi-asserted-by":"publisher","DOI":"10.1111\/cea.13614"},{"key":"2025032603000536000_34.175.240088.129","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2022.05.019"},{"key":"2025032603000536000_34.175.240088.130","unstructured":"Global Initiative for Asthma . Difficult-to-treat & severe asthma in adolescent and adult patients. Date last accessed: April 2024. Date last updated: July 2016. https:\/\/ginasthma.org\/wp-content\/uploads\/2019\/04\/GINA-Severe-asthma-Pocket-Guide-v2.0-wms-1.pdf"},{"key":"2025032603000536000_34.175.240088.131","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2022.02.002"},{"key":"2025032603000536000_34.175.240088.132","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2024.01.024"},{"key":"2025032603000536000_34.175.240088.133","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00260-2020"},{"key":"2025032603000536000_34.175.240088.134","unstructured":"AstraZeneca . Highlights of prescribing information. Date last accessed: April 2024. Date last updated: 26 May 2023. www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/761224s000lbl.pdf"},{"key":"2025032603000536000_34.175.240088.135","unstructured":"European Medicines Agency . Summary of product characteristics. Date last accessed: April 2024. Date last updated: 30 January 2024. www.ema.europa.eu\/en\/documents\/product-information\/tezspire-epar-product-information_en.pdf"},{"key":"2025032603000536000_34.175.240088.136","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1704064"},{"key":"2025032603000536000_34.175.240088.137","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034975"},{"key":"2025032603000536000_34.175.240088.138","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(22)00492-1"},{"key":"2025032603000536000_34.175.240088.139","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2024.04.031"},{"key":"2025032603000536000_34.175.240088.140","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2023.05.028"},{"key":"2025032603000536000_34.175.240088.141","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202210-2005OC"},{"key":"2025032603000536000_34.175.240088.142","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S342391"},{"key":"2025032603000536000_34.175.240088.143","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00226-5"},{"key":"2025032603000536000_34.175.240088.144","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01296-2021"},{"key":"2025032603000536000_34.175.240088.145","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00537-3"},{"key":"2025032603000536000_34.175.240088.146","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2023.107414"},{"key":"2025032603000536000_34.175.240088.147","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00606-2022"},{"key":"2025032603000536000_34.175.240088.148","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2021.03.022"},{"key":"2025032603000536000_34.175.240088.149","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2022.12.046"},{"key":"2025032603000536000_34.175.240088.150","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00117-2020"},{"key":"2025032603000536000_34.175.240088.151","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2023.10.046"},{"key":"2025032603000536000_34.175.240088.152","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2024.107720"},{"key":"2025032603000536000_34.175.240088.153","first-page":"A4830","article-title":"Clinical predictors of biological treatment failure in patients with severe eosinophilic asthma","volume":"205","author":"Reihman","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"2025032603000536000_34.175.240088.154","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01313-2021"},{"key":"2025032603000536000_34.175.240088.155","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00004-7"},{"key":"2025032603000536000_34.175.240088.156","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201707-1323OC"},{"key":"2025032603000536000_34.175.240088.157","doi-asserted-by":"crossref","first-page":"e00743","DOI":"10.1002\/rcr2.742","article-title":"Mepolizumab asthma treatment failure due to refractory airway eosinophilia, which responded to benralizumab","volume":"9","author":"Cook","year":"2021","journal-title":"Respirol Case Rep"},{"key":"2025032603000536000_34.175.240088.158","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202308-1413LE"},{"key":"2025032603000536000_34.175.240088.159","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S328653"},{"key":"2025032603000536000_34.175.240088.160","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2024.03.049"},{"key":"2025032603000536000_34.175.240088.161","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13111594"},{"key":"2025032603000536000_34.175.240088.162","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2024257"},{"key":"2025032603000536000_34.175.240088.163","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2022.09.008"},{"key":"2025032603000536000_34.175.240088.164","doi-asserted-by":"publisher","DOI":"10.1172\/JCI99726"},{"key":"2025032603000536000_34.175.240088.165","doi-asserted-by":"publisher","DOI":"10.1159\/000530392"},{"key":"2025032603000536000_34.175.240088.166","doi-asserted-by":"crossref","first-page":"EVIDoa2300135","DOI":"10.1056\/EVIDoa2300135","article-title":"Tezepelumab and mucus plugs in patients with moderate-to-severe asthma","volume":"2","author":"Nordenmark","year":"2023","journal-title":"NEJM Evid"},{"key":"2025032603000536000_34.175.240088.167","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202306-1102LE"},{"key":"2025032603000536000_34.175.240088.168","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.12.006"},{"key":"2025032603000536000_34.175.240088.169","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2023.08.609"},{"key":"2025032603000536000_34.175.240088.170","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2023.04.028"},{"key":"2025032603000536000_34.175.240088.171","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2023.01.037"},{"key":"2025032603000536000_34.175.240088.172","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2023.04.030"},{"key":"2025032603000536000_34.175.240088.173","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202311-2192OC"},{"key":"2025032603000536000_34.175.240088.174","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02583-2021"},{"key":"2025032603000536000_34.175.240088.175","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)02284-5"},{"key":"2025032603000536000_34.175.240088.176","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00404-2024"}],"container-title":["European Respiratory Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/16000617.0088-2024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T06:02:53Z","timestamp":1742968973000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/16000617.0088-2024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":176,"journal-issue":{"issue":"175","published-online":{"date-parts":[[2025,1,8]]},"published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1183\/16000617.0088-2024"],"URL":"https:\/\/doi.org\/10.1183\/16000617.0088-2024","relation":{},"ISSN":["0905-9180","1600-0617"],"issn-type":[{"value":"0905-9180","type":"print"},{"value":"1600-0617","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]}}}